58408 Federal Register / Vol. 75, No. 185 / Friday, September 24, 2010 / Notices 

unless the Part D appeals rules provide 

otherwise, the Part C appeals rules 

(including the annually adjusted AIC 

threshold amount) apply to Part D 

appeals to the extent they are 

appropriate. More specifically, 

§ 423.1970 and § 423.1976 of the Part D 

appeals rules discuss the AIC threshold 

amounts for ALJ hearings and judicial 

review. Section 423.1970(a) grants a Part 

D enrollee, who is dissatisfied with the 

Independent Review Entity (IRE) 

reconsideration determination, a right to 

an ALJ hearing if the amount remaining 

in controversy after the IRE 

reconsideration meets the threshold 

amount established annually by the 

Secretary. Sections 423.1976(a) and (b) 

allow a Part D enrollee to request 

judicial review of an ALJ or MAC 

decision if, in part, the AIC meets the 

threshold amount established annually 

by the Secretary. 

II. Annual AIC Adjustments 

A. AIC Adjustment Formula and AIC 

Adjustments 

As previously noted, section 940 of 

the MMA requires that the AIC 

threshold amounts be adjusted 

annually, beginning in January 2005, by 

the percentage increase in the medical 

care component of the consumer price 

index (CPI) for all urban consumers 

(U.S. city average) for July 2003 to the 

July of the preceding year involved and 

rounded to the nearest multiple of $10. 

B. Calendar Year 2011 

The AIC threshold amount for ALJ 

hearing requests will remain at $130 

and the AIC threshold amount for 

judicial review will rise to $1,300 for 

the 2011 calendar year. These updated 

amounts are based on the 30.34 percent 

increase in the medical care component 

of the CPI from July of 2003 to July of 

2010. The CPI level was at 297.6 in July 

of 2003 and rose to 387.898 in July of 

2010. This change accounted for the 

30.34 percent increase. The AIC 

threshold amount for ALJ hearing 

requests changes to $130.34 based on 

the 30.34 percent increase. In 

accordance with section 940 of the 

MMA, this amount is rounded to the 

nearest multiple of $10. Therefore, the 

2011 AIC threshold amount for ALJ 

hearings is $130. The AIC threshold 

amount for judicial review changes to 

$1,303.42 based on the 30.34 percent 

increase. This amount was rounded to 

the nearest multiple of $10, resulting in 

a 2011 AIC threshold amount of $1,300. 

C. Summary Table of Adjustments in 

the AIC Threshold Amounts 

In Table 1 below, we list the (CY) 

2005 through 2011 threshold amounts. 

TABLE 1—AMOUNT-IN-CONTROVERSY THRESHOLD AMOUNTS

CY 2005 CY 2006 CY 2007 CY 2008 CY 2009 CY 2010 CY 2011 

ALJ Hearing ......................................................................... $100 $110 $110 $120 $120 $130 $130 

Judicial Review .................................................................... 1,050 1,090 1,130 1,180 1,220 1,260 1,300 

* CY—Calendar Year. 

III. Collection of Information 

Requirements 

This document does not impose 

information collection and 

recordkeeping requirements. 

Consequently, it need not be reviewed 

by the Office of Management and 

Budget under the authority of the 

Paperwork Reduction Act of 1995 (44 

U.S.C. 35). 

(Catalog of Federal Domestic Assistance 

Program No. 93.778, Medical Assistance 

Program; No. 93.773 Medicare—Hospital 

Insurance Program; and No. 93.774, 

Medicare—Supplementary Medical 

Insurance Program) 

Dated: September 2, 2010. 

Donald M. Berwick, 

Administrator, Centers for Medicare & 

Medicaid Services. 

[FR Doc. 2010–23584 Filed 9–23–10; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Subcommittee on Procedures Review, 

Advisory Board on Radiation and 

Worker Health (ABRWH), National 

Institute for Occupational Safety and 

Health (NIOSH) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC), 

announces the following meeting of the 

aforementioned subcommittee: 

Time and Date: 9 a.m.–5 p.m., 

October 13, 2010. 

Place: Cincinnati Airport Marriott, 

2395 Progress Drive, Hebron, Kentucky 

41018. Telephone (859) 334–4611, Fax 

(859) 334–4619. 

Status: Open to the public, but 

without a public comment period. To 

access by conference call, dial the 

following information: (866) 659–0537, 

Participant Pass Code 9933701. 

Background: The ABRWH was 

established under the Energy Employees 

Occupational Illness Compensation 

Program Act of 2000 to advise the 

President on a variety of policy and 

technical functions required to 

implement and effectively manage the 

compensation program. Key functions of 

the ABRWH include providing advice 

on the development of probability of 

causation guidelines that have been 

promulgated by the Department of 

Health and Human Services (HHS) as a 

final rule; advice on methods of dose 

reconstruction which have also been 

promulgated by HHS as a final rule; 

advice on the scientific validity and 

quality of dose estimation and 

reconstruction efforts being performed 

for purposes of the compensation 

program; and advice on petitions to add 

classes of workers to the Special 

Exposure Cohort (SEC). 

In December 2000, the President 

delegated responsibility for funding, 

staffing, and operating the ABRWH to 

HHS, which subsequently delegated this 

authority to CDC. NIOSH implements 

this responsibility for CDC. The charter 

was issued on August 3, 2001, renewed 

at appropriate intervals, and will expire 

on August 3, 2011. 

Purpose: The ABRWH is charged with 

(a) providing advice to the Secretary, 

HHS, on the development of guidelines 

under Executive Order 13179; (b) 

providing advice to the Secretary, HHS, 

on the scientific validity and quality of 

dose reconstruction efforts performed 

for this program; and (c) upon request 

by the Secretary, HHS, advising the 

Secretary on whether there is a class of 

employees at any Department of Energy 

facility who were exposed to radiation 


srobinson on DSKHWCL6B1PROD with NOTICES
Federal Register / Vol. 75, No. 185 / Friday, September 24, 2010 / Notices 58409 

but for whom it is not feasible to 

estimate their radiation dose, and on 

whether there is a reasonable likelihood 

that such radiation doses may have 

endangered the health of members of 

this class. The Subcommittee on 

Procedures Review was established to 

aid the ABRWH in carrying out its duty 

to advise the Secretary, HHS, on dose 

reconstructions. The Subcommittee on 

Procedures Review is responsible for 

overseeing, tracking, and participating 

in the reviews of all procedures used in 

the dose reconstruction process by the 

NIOSH Division of Compensation 

Analysis and Support (DCAS) and its 

dose reconstruction contractor. 

Matters To Be Discussed: The agenda 

for the Subcommittee meeting includes: 

Review of draft prototype documents for 

informing the public on completed 

Subcommittee procedure reviews; 

discussion of the following ORAU & 

OCAS procedures: PER–012 

(‘‘Evaluation of Highly Insoluble 

Plutonium Compounds’’), PER–009 

(‘‘Target Organs for Lymphoma’’), OCAS 

TIB–0013 (‘‘Special External Dose 

Reconstruction Considerations for 

Mallinckrodt Workers’’), OTIB–014 

(‘‘Rocky Flats Internal Dosimetry CoWorker Extension’’), OTIB–019 

(‘‘Analysis of Co-worker Bioassay Data 

for Internal Dose Assignment’’), OTIB– 

0029 (‘‘Internal Dosimetry Co-worker 

Data for Y–12’’), OTIB–0049 

(‘‘Estimating Doses for Plutonium 

Strongly Retained in the Lung’’), OTIB– 

0047 (External Radiation Monitoring at 

the Y–12 Facility During the 1948–1949 

Period’’), OTIB–0051 (‘‘Effect of 

Threshold Energy and Angular 

Response of NTA Film on Missed 

Neutron Dose at the Oak Ridge Y–12 

Facility’’), OTIB–0052 (‘‘Parameters to 

Consider When Processing Claims for 

Construction Trade Workers’’), OTIB– 

0054 (‘‘Fission and Activation Product 

Assignment for Internal Dose-Related 

Gross Beta and Gross Gamma 

Analyses’’), OTIB–0057 (‘‘External 

Radiation Dose Estimates For 

Individuals Near the 1958 Criticality 

Accident at the Oak Ridge Y–12 Plant’’), 

OTIB–0070 (‘‘Dose Reconstruction 

During Residual Radioactivity Periods at 

Atomic Weapons Employer Facilities’’), 

and TBD 6000 (‘‘Site Profile for Atomic 

Weapons Employers that Worked 

Uranium and Thorium Metals’’); and a 

continuation of the comment-resolution 

process for other dose reconstruction 

procedures under review by the 

Subcommittee. 

The agenda is subject to change as 

priorities dictate. 

This meeting is open to the public, 

but without a public comment period. 

In the event an individual wishes to 

provide comments, written comments 

may be submitted. Any written 

comments received will be provided at 

the meeting and should be submitted to 

the contact person below in advance of 

the meeting. 

Contact Person for More Information: 

Theodore Katz, Designated Federal 

Officer, NIOSH, CDC, 1600 Clifton 

Road, Mailstop E–20, Atlanta, Georgia 

30333, Telephone (513) 533–6800, Toll 

Free 1 (800) CDC–INFO, E-mail 

dcas@cdc.gov. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both CDC 

and the Agency for Toxic Substances 

and Disease Registry. 

Dated: September 17, 2010. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2010–24006 Filed 9–23–10; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Dental & 

Craniofacial Research; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Dental and Craniofacial Research Special 

Emphasis Panel; Scientific Review of P01 

Applications submitted to PAR 08–117. 

Date: October 20, 2010. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Courtyard by Marriott, 5520 

Wisconsin Avenue, Chevy Chase, MD 20815. 

Contact Person: Marilyn Moore-Hoon, PhD, 

Scientific Review Officer, Scientific Review 

Branch, National Institute of Dental and 

Craniofacial Research, 6701 Democracy 

Blvd., Rm. 676, Bethesda, MD 20892–4878, 

301–594–4861, mooremar@nidcr.nih.gov. 

Name of Committee: National Institute of 

Dental and Craniofacial Research Special 

Emphasis Panel; RFA DE–11–001 

Collaborative Research on the Transition 

From Acute to Chronic Pain: New Models 

and Measures in Clinical and Preclinical Pain 

Research (R01). 

Date: October 28, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Crowne Plaza Hotel—Silver Spring, 

8777 Georgia Avenue, 8777 Georgia Avenue, 

Silver Spring, MD 20910. 

Contact Person: Victor Henriquez, PhD, 

Scientific Review Officer, DEA/SRB/NIDCR, 

6701 Democracy Blvd., Room 668, Bethesda, 

MD 20892–4878, 301–451–2405, 

henriquv@nidcr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.121, Oral Diseases and 

Disorders Research, National Institutes of 

Health, HHS) 

Dated: September 20, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–23951 Filed 9–23–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Dental & 

Craniofacial Research; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Dental and Craniofacial Research Special 

Emphasis Panel; Review F30s, R03. 

Date: October 18, 2010. 

Time: 2:30 p.m. to 3:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, One 

Democracy Plaza, 6701 Democracy 

Boulevard, Bethesda, MD 20892 (Telephone 

Conference Call). 

Contact Person: Mary Kelly, Scientific 

Review Officer, Scientific Review Branch, 


srobinson on DSKHWCL6B1PROD with NOTICES